For patients needing rapid, lab-quality diagnostic results, Novel Microdevices has secured $1.0M in new funding to advance its portable testing platform.
The company's Novel Dx system aims to provide clinically actionable results in under 30 minutes, allowing for immediate testing and treatment during a single visit, anywhere. It achieves this by detecting the genetic material of pathogens through Nucleic Acid Amplification techniques, bringing the precision of large reference laboratories to a compact, accessible format.
